ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ATRI ATRION Corporation

398.97
-25.22 (-5.95%)
Apr 25 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 31,403
Bid Price 160.29
Ask Price 641.08
News -
Day High 420.01

Low
274.98

52 Week Range

High
643.48

Day Low 396.23
Share Name Share Symbol Market Stock Type
ATRION Corporation ATRI NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-25.22 -5.95% 398.97 19:00:00
Open Price Low Price High Price Close Price Previous Close
420.01 396.23 420.01 398.97 424.19
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
5,150 31,403 US$ 411.86 US$ 12,933,489 - 274.98 - 643.48
Last Trade Type Quantity Price Currency
15:20:00 55 US$ 398.97 USD

ATRION Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
703.69M 1.76M - 169.33M 19.41M 11.03 36.25
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ATRION News

Date Time Source News Article
3/11/202410:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/29/202415:06Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/29/202415:00Edgar (US Regulatory)Form 8-K - Current report
2/29/202415:00GlobeNewswire Inc.Atrion Reports Fourth Quarter And Full Year 2023 Results
2/27/202412:20GlobeNewswire Inc.Atrion Corporation Declares Quarterly Cash Dividend
2/12/202412:55Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
1/29/202414:26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
1/03/202416:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/03/202416:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/28/202313:36Edgar (US Regulatory)Form 8-K - Current report
12/01/202313:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/27/202315:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ATRI Message Board. Create One! See More Posts on ATRI Message Board See More Message Board Posts

Historical ATRI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week403.56425.265381.12402.7731,200-4.59-1.14%
1 Month444.21468.00374.835411.9730,487-45.24-10.18%
3 Months341.06468.00320.00409.8819,96957.9116.98%
6 Months332.00468.00274.98387.4214,10766.9720.17%
1 Year634.09643.48274.98411.269,017-235.12-37.08%
3 Years651.40805.62274.98535.116,272-252.43-38.75%
5 Years881.36922.80274.98631.267,601-482.39-54.73%

ATRION Description

Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.

Your Recent History

Delayed Upgrade Clock